BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27506939)

  • 1. Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide.
    Jacob L; Sawma P; Garnier N; Meyer LA; Fritz J; Hussenet T; Spenlé C; Goetz J; Vermot J; Fernandez A; Baumlin N; Aci-Sèche S; Orend G; Roussel G; Crémel G; Genest M; Hubert P; Bagnard D
    Oncotarget; 2016 Sep; 7(36):57851-57865. PubMed ID: 27506939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprenaline/β2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.
    Lu Y; Xu Q; Zuo Y; Liu L; Liu S; Chen L; Wang K; Lei Y; Zhao X; Li Y
    BMC Cancer; 2017 Dec; 17(1):875. PubMed ID: 29262812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plexin-B1 indirectly affects glioma invasiveness and angiogenesis by regulating the RhoA/αvβ3 signaling pathway and SRPK1.
    Chang Y; Li L; Zhang L; Guo X; Feng Z; Zhou J; Zhou S; Feng G; Han F; Huang W; Yang J; Huang F
    Tumour Biol; 2016 Aug; 37(8):11225-36. PubMed ID: 26944058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juglone reduces growth and migration of U251 glioblastoma cells and disrupts angiogenesis.
    Wang J; Liu K; Wang XF; Sun DJ
    Oncol Rep; 2017 Oct; 38(4):1959-1966. PubMed ID: 28791366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plexin-B2 promotes invasive growth of malignant glioma.
    Le AP; Huang Y; Pingle SC; Kesari S; Wang H; Yong RL; Zou H; Friedel RH
    Oncotarget; 2015 Mar; 6(9):7293-304. PubMed ID: 25762646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling.
    Kigel B; Rabinowicz N; Varshavsky A; Kessler O; Neufeld G
    Blood; 2011 Oct; 118(15):4285-96. PubMed ID: 21832283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the plexin-A2 receptor in Sema3A and Sema3B signal transduction.
    Sabag AD; Smolkin T; Mumblat Y; Ueffing M; Kessler O; Gloeckner CJ; Neufeld G
    J Cell Sci; 2014 Dec; 127(Pt 24):5240-52. PubMed ID: 25335892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of Plexin A1 in gastric carcinoma and its relationship with tumor angiogenesis and proliferation].
    Zhao XY; Chen L; Xu Q; Li YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):265-8. PubMed ID: 17520388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epo is involved in angiogenesis in human glioma.
    Nico B; Annese T; Guidolin D; Finato N; Crivellato E; Ribatti D
    J Neurooncol; 2011 Mar; 102(1):51-8. PubMed ID: 20614229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
    Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
    Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrandrine suppresses human glioma growth by inhibiting cell survival, proliferation and tumour angiogenesis through attenuating STAT3 phosphorylation.
    Ma JW; Zhang Y; Li R; Ye JC; Li HY; Zhang YK; Ma ZL; Li JY; Zhong XY; Yang X
    Eur J Pharmacol; 2015 Oct; 764():228-239. PubMed ID: 26086859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane recognition of the semaphorin co-receptors neuropilin 1 and plexin A1: coarse-grained simulations.
    Aci-Sèche S; Sawma P; Hubert P; Sturgis JN; Bagnard D; Jacob L; Genest M; Garnier N
    PLoS One; 2014; 9(5):e97779. PubMed ID: 24858828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.
    Bernard H; Garmy-Susini B; Ainaoui N; Van Den Berghe L; Peurichard A; Javerzat S; Bikfalvi A; Lane DP; Bourdon JC; Prats AC
    Oncogene; 2013 Apr; 32(17):2150-60. PubMed ID: 22733133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
    Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
    J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessibilome of human glioblastoma: collagen-VI-alpha-1 is a new target and a marker of poor outcome.
    Turtoi A; Blomme A; Bianchi E; Maris P; Vannozzi R; Naccarato AG; Delvenne P; De Pauw E; Bevilacqua G; Castronovo V
    J Proteome Res; 2014 Dec; 13(12):5660-9. PubMed ID: 25325876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
    Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
    Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasorin stimulates malignant progression and angiogenesis in glioma.
    Liang W; Guo B; Ye J; Liu H; Deng W; Lin C; Zhong X; Wang L
    Cancer Sci; 2019 Aug; 110(8):2558-2572. PubMed ID: 31215106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.
    Pisati F; Belicchi M; Acerbi F; Marchesi C; Giussani C; Gavina M; Javerzat S; Hagedorn M; Carrabba G; Lucini V; Gaini SM; Bresolin N; Bello L; Bikfalvi A; Torrente Y
    Cancer Res; 2007 Apr; 67(7):3054-63. PubMed ID: 17409412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
    Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
    Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.